Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Apple Watch released in the September 12 product launch. Photo: Qi Heng/VCG via Getty Images
Apple expanded its health care footprint yesterday with its latest Apple Watch, adding features that can monitor users' heart rates and also detect falls.
The big picture: Apple is carving out a consistent niche for itself as the tech industry more broadly searches for ways into the health care market.
- The fitness and health monitoring functions of the Apple Watch are already one of the company's selling points, and its recent move to help consumers more easily access and store their own health records has gotten good reviews.
There are limits to the watch's new capabilities. The Food and Drug Administration signed off on Apple's heart-monitoring features, but said consumers should use them "for informational purposes only" and should not use them as the basis for any clinical decisions without consulting a doctor first.
Doctors said the new features could help patients quickly identify an irregular heartbeat, but could also lead to false positives and over-treatment.
- One cardiologist "said it isn’t clear whether the watch’s benefits in detecting asymptomatic cases outweigh such risks," the Wall Street Journal reports.
- He's not alone, as UCSF scientist Ethan Weiss tweets: